Skip to content

Skip to secondary menu

Jehovah’s Witnesses


Sickle Cell Disease (Pediatrics)

Transfusion Risks and Uncertainties

Prevalence of human immunodeficiency virus transmission among transfused children with sickle cell anemia in Enugu Nigeria.

Ubesie A, Emodi I, Ikefuna A, Ilechukwu G, Ilechukwu G.

Source‎: Ann Med Health Sci Res 2012;2(2):109-13.

Indexed‎: PubMed 23439999

DOI‎: 10.4103/2141-9248.105655

Primary hemorrhagic stroke in children with sickle cell disease is associated with recent transfusion and use of corticosteroids.

Strouse JJ, Hulbert ML, DeBaun MR, Jordan LC, Casella JF.

Source‎: Pediatrics 2006;118(5):1916-24.

Indexed‎: PubMed 17079562

Delayed hemolytic transfusion reaction/hyperhemolysis syndrome in children with sickle cell disease.

Talano JA, Hillery CA, Gottschall JL, Baylerian DM, Scott JP.

Source‎: Pediatrics 2003;111(6 Pt 1):e661-5.

Indexed‎: PubMed 12777582

The medical section of is designed as an informational resource primarily for use by clinicians and other health-care professionals. It provides neither medical advice nor treatment recommendations and does not substitute for an appropriately qualified health-care provider. The clinical literature cited is not published by Jehovah’s Witnesses, but it outlines transfusion-alternative strategies that might be considered. It is the responsibility of each qualified health-care provider to maintain awareness of new information, discuss options for care, and assist patients in making choices in accord with their medical condition, wishes, values, and beliefs. Not all listed strategies are appropriate or acceptable to all patients.

Patients: Always seek the advice of your doctor or other qualified health-care provider regarding medical conditions or treatments. Check with a doctor if you suspect you are ill.

The use of this website is governed by its terms of use.